Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

CRISIS AFAR: An International Collaborative Study of the Impact of the COVID-19 Pandemic on Youth with Autism and Neurodevelopmental Conditions

Bethany Vibert, Patricia Segura, Louise Gallagher, Stelios Georgiades, Panagiota Pervanidou, Audrey Thurm, Lindsay Alexander, Evdokia Anagnostou, Yuta Aoki, Catherine S.N. Birken, Somer L. Bishop, Jessica Boi, Carmela Bravaccio, Helena Brentani, View ORCID ProfilePaola Canevini, Alessandra Carta, Alice Charach, Antonella Costantino, Katherine T. Cost, Elaine Andrade Cravo, Jennifer Crosbie, Chiara Davico, Alessandra Gabellone, Federica Donno, Junya Fujino, Cristiane Tezzari Geyer, Tomoya Hirota, Stephen Kanne, Makiko Kawashima, Elizabeth Kelley, Hosanna Kim, Young Shin Kim, So Hyun (Sophy) Kim, View ORCID ProfileDaphne J. Korczak, View ORCID ProfileMeng-Chuan Lai, Lucia Margari, Gabriele Masi, Lucia Marzulli, Luigi Mazzone, Jane McGrath, Suneeta Monga, Paola Morosini, Shinichiro Nakajima, Antonio Narzisi, Rob Nicolson, Aki Nikolaidis, Yoshihiro Noda, Kerri Nowell, Miriam Polizzi, Joana Portolese, Maria Pia Riccio, Manabu Saito, Anish K. Simhal, Martina Siracusano, Stefano Sotgiu, Jacob Stroud, Fernando Sumiya, Ida Schwartz, Yoshiyuki Tachibana, Nicole Takahashi, Riina Takahashi, Hiroki Tamon, Raffaella Tancredi, Benedetto Vitiello, Alessandro Zuddas, Bennett Leventhal, Kathleen Merikangas, Michael P Milham, Adriana Di Martino
doi: https://doi.org/10.1101/2022.04.27.22274269
Bethany Vibert
1Autism Center, Child Mind Institute, New York, NY, USA
PsyD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patricia Segura
1Autism Center, Child Mind Institute, New York, NY, USA
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louise Gallagher
2Department of Psychiatry, School of Medicine, Trinity College Dublin, Dublin, Ireland
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stelios Georgiades
3Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Panagiota Pervanidou
4University of Athens, National & Kapodistrian University of Athens, School of Medicine, First Department of Pediatrics, Unit of Developmental and Behavioral Pediatrics. “Aghia Sophia” Children’s Hospital, Athens, Greece
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Audrey Thurm
5Neurodevelopmental and Behavioral Phenotyping Service, National Institute of Mental Health, Bethesda, Maryland, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lindsay Alexander
6Center for the Developing Brain, Child Mind Institute, New York, NY, USA
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Evdokia Anagnostou
7Autism Research Centre, Bloorview Research Institute, Holland Bloorview Kids Rehabilitation Hospital, Toronto, ON, Canada
8Department of Paediatrics, University of Toronto, Toronto, ON, Canada
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuta Aoki
9Medical Institute of Developmental Disabilities Research, Showa University, Tokyo, Japan
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine S.N. Birken
10Department of Pediatrics, School of Medicine, University of Toronto, Toronto, ON, Canada
11Division of Paediatric Medicine, Hospital for Sick Children, Toronto, ON, Canada
MD, MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Somer L. Bishop
12Department of Psychiatry and Behavioral Sciences and Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica Boi
13Department of Biomedical Sciences, Section of Neuroscience & Clinical Pharmacology, University of Cagliari, Cagliari, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carmela Bravaccio
14UOSD di Neuropsichiatria Infantile - Dipartimento di Scienze Mediche Traslazionali, Università Federico II di Napoli - Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helena Brentani
15Department of Psychiatry, Hospital das Clinicas HCFMUSP, Faculty of Medicine, University of São Paulo (USP), São Paulo, Brazil
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paola Canevini
16Department of Health Sciences, Università degli Studi di Milano,Milan, Italy
17Epilepsy Center - Sleep Medicine Center, Childhood and Adolescence Neuropsychiatry Unit, ASST SS. Paolo e Carlo, San Paolo Hospital, Milan, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paola Canevini
Alessandra Carta
18Department of Medical Surgical and Experimental Sciences, Unit of Child Neuropsychiatry, University Hospital of Sassari, Sassari, Italy
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alice Charach
19Department of Psychiatry, Hospital for Sick Children, Peter Gilgan Centre for Research and Learning, 686 Bay Street, 6th Floor, Toronto, On, M5G 0A4, Canada
20Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada
MD, MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonella Costantino
21Child and Adolescent Neuropsychiatric Unit, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katherine T. Cost
19Department of Psychiatry, Hospital for Sick Children, Peter Gilgan Centre for Research and Learning, 686 Bay Street, 6th Floor, Toronto, On, M5G 0A4, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elaine Andrade Cravo
22Department of Psychiatry, School of Medicine, Universidade Federal do Paraná, Curitiba, PR, Brazil
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Crosbie
19Department of Psychiatry, Hospital for Sick Children, Peter Gilgan Centre for Research and Learning, 686 Bay Street, 6th Floor, Toronto, On, M5G 0A4, Canada
20Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chiara Davico
23Department of Public Health and Pediatric Sciences, Section of Child and Adolescent Neuropsychiatry, University of Turin, Turin, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alessandra Gabellone
24Department of Biomedical Sciences and Human Oncology, University of Bari “Aldo Moro”, Bari, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Federica Donno
13Department of Biomedical Sciences, Section of Neuroscience & Clinical Pharmacology, University of Cagliari, Cagliari, Italy
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Junya Fujino
25Department of Psychiatry and Behavioral Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cristiane Tezzari Geyer
22Department of Psychiatry, School of Medicine, Universidade Federal do Paraná, Curitiba, PR, Brazil
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomoya Hirota
26Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, California, USA
27Department of Neuropsychiatry, Graduate School of Medicine, Hirosaki University, Hirosaki, Aomori, Japan
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Kanne
28Center for Autism and the Developing Brain, Department of Psychiatry, Weill Cornell Medicine, New York, NY
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Makiko Kawashima
29Koishikawa Tokyo Hospital, Tokyo, Japan
MP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth Kelley
30Department of Psychology, Queens University, Kingston, ON, Canada
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hosanna Kim
31The UCSF Center for ASD & NDDs, University of California San Francisco, San Francisco, California
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Young Shin Kim
31The UCSF Center for ASD & NDDs, University of California San Francisco, San Francisco, California
MD, PhD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
So Hyun (Sophy) Kim
28Center for Autism and the Developing Brain, Department of Psychiatry, Weill Cornell Medicine, New York, NY
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daphne J. Korczak
19Department of Psychiatry, Hospital for Sick Children, Peter Gilgan Centre for Research and Learning, 686 Bay Street, 6th Floor, Toronto, On, M5G 0A4, Canada
20Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada
MD, MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Daphne J. Korczak
Meng-Chuan Lai
20Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada
32Autism Research Centre, Department of Psychiatry, University of Cambridge, Cambridge, UK
33Centre for Addiction and Mental Health Toronto, Ontario, Canada
34Department of Psychiatry, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Meng-Chuan Lai
Lucia Margari
24Department of Biomedical Sciences and Human Oncology, University of Bari “Aldo Moro”, Bari, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabriele Masi
35IRCCS Stella Maris Foundation, Pisa (Calambrone), Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lucia Marzulli
24Department of Biomedical Sciences and Human Oncology, University of Bari “Aldo Moro”, Bari, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luigi Mazzone
36Child Neurology and Psychiatry Unit, Systems Medicine Department, University of Rome Tor Vergata, Rome, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jane McGrath
2Department of Psychiatry, School of Medicine, Trinity College Dublin, Dublin, Ireland
37ADMiRE, Linn Dara Child and Adolescent Mental Health Services, Cherry Orchard Hospital, Ballyfermot, Dublin, Ireland
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suneeta Monga
19Department of Psychiatry, Hospital for Sick Children, Peter Gilgan Centre for Research and Learning, 686 Bay Street, 6th Floor, Toronto, On, M5G 0A4, Canada
20Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paola Morosini
38Unita’ Operativa di Neuropsichiatria dell’ Infanzia e dell’ adolescenza, Lodi, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shinichiro Nakajima
39Keio University School of Medicine, Tokyo, Japan
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonio Narzisi
35IRCCS Stella Maris Foundation, Pisa (Calambrone), Italy
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rob Nicolson
40Department of Psychiatry, University of Western Ontario, London, Ontario
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aki Nikolaidis
6Center for the Developing Brain, Child Mind Institute, New York, NY, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshihiro Noda
39Keio University School of Medicine, Tokyo, Japan
MD, PhD, MBA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kerri Nowell
41Thompson Center of Neurodevelopmental Disorders, University of Missouri, Columbia, MO, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miriam Polizzi
14UOSD di Neuropsichiatria Infantile - Dipartimento di Scienze Mediche Traslazionali, Università Federico II di Napoli - Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joana Portolese
15Department of Psychiatry, Hospital das Clinicas HCFMUSP, Faculty of Medicine, University of São Paulo (USP), São Paulo, Brazil
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Pia Riccio
14UOSD di Neuropsichiatria Infantile - Dipartimento di Scienze Mediche Traslazionali, Università Federico II di Napoli - Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manabu Saito
27Department of Neuropsychiatry, Graduate School of Medicine, Hirosaki University, Hirosaki, Aomori, Japan
42Research Center for Child Mental Development, Graduate School of Medicine, Hirosaki University, Hirosaki, Japan
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anish K. Simhal
1Autism Center, Child Mind Institute, New York, NY, USA
43Medical Physics, Memorial Sloan Kettering Cancer Center, NY, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martina Siracusano
36Child Neurology and Psychiatry Unit, Systems Medicine Department, University of Rome Tor Vergata, Rome, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefano Sotgiu
18Department of Medical Surgical and Experimental Sciences, Unit of Child Neuropsychiatry, University Hospital of Sassari, Sassari, Italy
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacob Stroud
1Autism Center, Child Mind Institute, New York, NY, USA
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fernando Sumiya
15Department of Psychiatry, Hospital das Clinicas HCFMUSP, Faculty of Medicine, University of São Paulo (USP), São Paulo, Brazil
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ida Schwartz
44Medical Genetics Service/HCPA, Genetics Department/UFRGS, Brazil
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshiyuki Tachibana
45Division of Infant and Toddler Mental Health, Department of Psychosocial Medicine, National Center for Child Health and Development, Tokyo, Japan
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicole Takahashi
41Thompson Center of Neurodevelopmental Disorders, University of Missouri, Columbia, MO, USA
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Riina Takahashi
29Koishikawa Tokyo Hospital, Tokyo, Japan
MP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroki Tamon
45Division of Infant and Toddler Mental Health, Department of Psychosocial Medicine, National Center for Child Health and Development, Tokyo, Japan
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raffaella Tancredi
35IRCCS Stella Maris Foundation, Pisa (Calambrone), Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benedetto Vitiello
23Department of Public Health and Pediatric Sciences, Section of Child and Adolescent Neuropsychiatry, University of Turin, Turin, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alessandro Zuddas
13Department of Biomedical Sciences, Section of Neuroscience & Clinical Pharmacology, University of Cagliari, Cagliari, Italy
46Child & Adolescent Neuropsychiatry Unit, “A.Cao” Paediatric Hospital, Cagliari, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bennett Leventhal
47University of Chicago, Chicago, IL, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathleen Merikangas
48Genetic Epidemiology Research Branch, Intramural Research Program, National Institute of Mental Health, Bethesda, MD, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael P Milham
6Center for the Developing Brain, Child Mind Institute, New York, NY, USA
49Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY, USA
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adriana Di Martino
1Autism Center, Child Mind Institute, New York, NY, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: adriana.dimartino{at}childmind.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Importance Heterogeneous mental health outcomes during the COVID-19 pandemic are recognized in the general population, but it has not been systematically assessed in youth with neurodevelopmental disorders (NDD), including autism spectrum (ASD).

Objective Identify subgroups of youth with ASD/NDD based on the pandemic impact on symptoms and service changes, as well as predictors of outcomes.

Design, Setting, and Participants This is a naturalistic observational study conducted across 14 North American and European clinical and/or research sites. Parent responses on the Coronavirus Health and Impact Survey Initiative (CRISIS) adapted for Autism and Related Neurodevelopmental Conditions (AFAR) were cross-sectionally collected from April to October 2020. The sample included 1275, 5-21 year-old youth with ASD and/or NDD who were clinically well-characterized prior to the pandemic.

Main Outcomes and Measures To identify impact subgroups, hierarchical clustering analyzed eleven AFAR factors measuring pre- to pandemic changes in clinically relevant symptoms and service access. Random forest classification assessed the relative contribution in predicting subgroup membership of 20 features including socio-demographics, pre-pandemic service, and clinical severity along with indices of COVID-19 related experiences and environments empirically-derived from AFAR parent responses and global open sources.

Results Clustering analyses revealed four ASD/NDD impact subgroups. One subgroup - broad symptom worsening only (20% of the aggregate sample) - included youth with worsening symptoms that were above and beyond that of their ASD/NDD peers and with similar service disruptions as those in the aggregate average. The three other subgroups showed symptom changes similar to the aggregate average but differed in service access: primarily modified services (23%), primarily lost services (6%), and average services/symptom changes (53%). Pre-pandemic factors (e.g., number of services), pandemic environments and experiences (e.g., COVID-19 cases, related restrictions, COVID-19 Worries), and age emerged in unique combinations as distinct protective or risk factors for each subgroup. Together they highlighted the role of universal risk factors, such as risk perception, and the protective role of services before and during the pandemic, in middle childhood.

Conclusions and Relevance Concomitant assessment of changes in both symptoms and services access is critical to understand heterogeneous impact of the pandemic on ASD/NDD youth. It enabled the delineation of pathways to risk and resilience that include universal and ASD/NDD specific contributors.

INTRODUCTION

Pediatric populations are vulnerable to the sudden and pervasive disruptions in their daily life, such as those brought by the COVID-19 pandemic.1,2 Those with neurodevelopmental disorders (NDD) have been identified by parents, educators, clinicians, and policy makers, as requiring specific attention due to the range of preexisting behavioral, emotional, and learning difficulties.3–5 Empirical reports support this notion highlighting disruptions in ongoing care6–9 and increases in behavioral and emotional difficulties in youth with NDD since the start of the pandemic.9–21 Here, we report our international effort to assess heterogeneity in the impact of the COVID-19 pandemic and predictors of outcomes in previously well-characterized youth with autism spectrum disorder (ASD) and/or other NDD.

The focus on variable outcomes is motivated by prior clinical and disaster research. Clinical literature indicates that ASD/NDD are highly heterogeneous in symptom presentations, comorbidities, intellectual abilities, and adaptive functioning.22–24 Disaster research, before and during the COVID-19 pandemic, has shown that the degree of severity of prior mental illness, disaster exposure, and perceived risk, are predictors of negative outcomes.19,21,25–27 A comprehensive understanding of the contribution of both disaster- and clinically-related predictors of outcomes in youth with ASD/NDD is needed to inform recovery efforts and prepare for future crises.

Towards this goal, we adapted the Coronavirus Health and Impact Survey Initiative (CRISIS)27 for Autism and Related Neurodevelopmental Conditions (AFAR). CRISIS was designed to capture the multifaceted nature of risk during the COVID-19 pandemic in the general population by quantitatively assessing life changes, perceived risk, and worries about COVID-19, as well as mental health before and during the pandemic. Previous work in the general population established CRISIS psychometrics and feasibility in delineating distinct life stress profiles and their predictive role in mental health outcomes.27,28 While preserving the original structure of CRISIS, AFAR aimed to quantify changes in domains affected by or known to impact changes in daily life and therapeutic services in ASD/NDD. To investigate the contributions of pandemic-related aspects, such as COVID-19 case rates and restrictions, and optimize the balance between sample size and characterization, we formed a collaborative international network of investigators aiming to collect AFAR surveys from previously well-characterized youth with ASD/NDD in a naturalistic observational framework. Using multivariate data-driven analyses in a cross-sectional AFAR dataset of N=1275 individuals, we identified distinct subgroups of impact and their predictors.

METHODS

Survey Development

A workgroup of ASD/NDD experts (ADM, LG, SG, PP, AT, BV) led the adaptation from the CRISIS Parent/Caregiver Baseline Form. The adaptation included assessments of clinical domains relevant to ASD/NDD and services, while maintaining the existing structure of CRISIS.27,29 Empirical evidence on the impact of disasters on ASD/NDD was limited to one study reporting worsening in adaptive funcitoning.30 Therefore, along with adaptive skills, we prioritized the assessment of symptoms known to be affected by or to impact adjustment. These encompassed restricted and repetitive behaviors/interests (RRB)31–33 externalizing and internalizing symptoms that often co-occur in ASD/NDD.22,24 Parent/caregiver questions were developed to target observable behaviors rather than reporting internal states. To contain the survey length, the CRISIS Mood State and Substance Use domains were dropped. Like CRISIS, symptoms were rated on a Likert-scale based on three months prior to the COVID-19 start in the respondent’s geographical area and over the two weeks prior to completion (Prior and Current time points, respectively).

To evaluate changes in service access, we derived items from a survey developed during the pandemic for people with syndromic intellectual disabilities and their caregivers.8 Questions queried changes in therapeutic services typically received both within and outside school settings in the respondents geographical area, following the start of the pandemic. The remainder of the original CRISIS was unchanged, except for some rewordings or additional response options (e.g., sleep problems), as detailed in eFigure1 and Methods in eAppendix.

Like CRISIS, questions were developed for individuals aged five to 21 years; a later review identified a subset of questions developmentally applicable for ages as young as three years (eFigure 1, Supplementary Methods). The initial adaptation was developed in English and then translated into five other languages and updated with rewordings in consultation with the larger AFAR network. The final version 0.5.1 of AFAR Parent/Caregiver Baseline Form (3-21) included 96 independent items, with 34 questions asked twice for Prior and Current timepoints; AFAR is freely available for use by other investigators.29

Data Collection

AFAR Parent/Caregiver Baseline surveys were collected in 15 samples at 14 research and/or clinical institutions in Europe and North America. Data were collected cross-sectionally over the first six months of the pandemic (April-October 2020; Figure1A, eTable1, Methods in eAppendix). Parents of children aged three to 21 years with previously established clinician-based DSM-IV/534,35 or ICD-1036 diagnosis of ASD and/or other NDD were invited to complete AFAR. Along with diagnostics, when feasible, previously collected information on intellectual functioning and symptoms were shared. IRB approval for collection and sharing of de-identified AFAR and related data was obtained at each institution.

Figure 1.
  • Download figure
  • Open in new tab
Figure 1. Data Collection Time Periods and Characteristics

a) Data Collection Times for each contributing samples (a) and their characteristics (b) Abbreviations: CMI-AC=Child Mind Institute-Autism Center; CMI-HBN=CMI-Healthy Brain Network; TC=Thompson Center; UCSF=University of California San Francisco; CADB=Center for Autism and Developing Brain, Weill Cornell Medical College/New York Presbyterian Hospital; UAth=University of Athens, National & Kapodistrian University of Athens, School of Medicine, First Department of Pediatrics, Unit of Developmental and Behavioral Pediatrics. “Aghia Sophia” Children’s Hospital; POND-CMH=Province of Ontario Neurodevelopmental Network, COvid Mental Health collaboration; TCD=Trinity College Dublin; UCA=University of Cagliari, Child & Adolescent Neuropsychiatry Unit, A.Cao Paediatric Hospital; UBA=University Bari, Child Neuropsychiatry Unit, Policlinic of Bari; UFII=University of Naples Federico II, Child and Adolescent Neuropsychiatry Unit; SMF=Stella Maris Foundation, University of Pisa; UTV=University Tor Vergata; USS=University of Sassari, Child Neuropsychiatry Unit, Azienda Ospedaliero-Universitaria; UONPI-LO=Unita’ Operativa di Neuropsichiatria dell’ Infanzia e dell’ adolescenza, Lodi; ASD=Autism Spectrum Disorder, ADHD=Attention-Deficit/ Hyperactivity Disorder; ID=Intellectual Disability. See eTable 1 and Methods in eAppendix for details on data collection protocols.

Data Selection

Data selection criteria for analyses were: 1) AFAR survey completion within the completion time interval for 90% of a given sample, to exclude outliers regarding COVID-19 infection rates and related responses for that sample; 2) age five years and above, as not all domains examined applied to younger children; 3) available AFAR variables included in clustering analyses.

Analyses

Overview

Across the aggregate sample, exploratory (EFA) and confirmatory factor analyses (CFA) were used to identify the AFAR scores. For consistency with earlier literature and interpretation of results, repeated measures MANCOVA examined group level pandemic effects on symptom changes (Prior versus Current), accounting for site. Measures of central tendency (mean and proportions) describe the total number of services lost or continued within and outside school. Hierarchical clustering (HC) and Random Forest (RF) classification served to identify pandemic impact subgroups and their predictors, respectively. The code used for factor analyses, HC and RF can be found at github.com/ChildMindInstitute/CRISIS-AFAR-analyses.

Factor Analyses

EFA and CFA were conducted in split-half datasets, group-matched by contributing sample, sex, child age, Full Intelligence Quotient (FIQ), and primary diagnosis (i.e., ASD, attention-deficit/hyperactivity disorder [ADHD] without ASD, Other NDD). EFA was first conducted across items included in the survey domains. Then, items with resulting factor loadings ≥0.3 were included in subsequent CFA. Items were removed, as needed, to yield factors composed of more than one item, meeting at least two of four goodness-of-fit-criteria, and theoretical plausibility. For the four domains designed to assess Prior and Current behaviors, EFA and CFA were conducted using the Prior scores; then, their stability was assessed via a CFA on items using the Current scores across the whole sample, (see Methods in eAppendix).

Hierarchical Clustering

To identify homogeneous subgroups with distinct profiles across 11 features of symptom and service changes, we performed agglomerative hierarchical clustering.37,38 Seven features reflected changes in clinically relevant symptoms for ASD/NDD, indexed by differences between Current and Prior scores on domains identified in factors analyses (Supplementary Methods). The remaining four features included the total number of services that were either lost or continued within and outside school. All scores were converted to standard z scores prior to clustering. Clusters (i.e., subgroups) were characterized by deviations from the aggregate sample average. The optimal cluster solution was determined using the NbClust,39 according to a majority rule among multiple goodness of fit measures.

Random Forest

We assessed the relative contribution of 20 features in predicting the COVID-19 pandemic subgroup (Figure 2A, Supplementary methods). These included family and child socio-demographics, their pandemic experiences, COVID-19 pandemic factors such as government responses, new COVID-19 infection rates empirically derived from open-data sources,40–42 as well as pre-pandemic service received and clinical severity. The latter was indexed by a summary Prior (baseline) score computed across the 7 AFAR symptom domains, this summary score was significantly correlated with previously collected standardized measures in datasets with those data available (eFigure 6, Methods in eAppendix). Based on a previously established analytical RF framework,43–45 feature importance was calculated using the permutation importance method45 and indexed as the average out-of-bag-error (OOBE), computed across 4000 bootstrapped samples (⅔ training, ⅓ testing). The larger the OOBE value, the greater the importance for a given feature (Methods in eAppendix).

Figure 2.
  • Download figure
  • Open in new tab
Figure 2. Prediction of COVID-19 Impact

a) The Venn diagram shows the 20 features selected for the Random Forest analysis across three partially overlapping domains: Child (socio– demographics, clinical characteristics before and during the pandemic; in red); COVID-19 pandemic factors (COVID-19 rates and related restrictions, and time since pandemic started; in yellow); and Family/Household factors (urbanicity, household composition and respondent education; blue). b) Feature ranking by mean OOBE importance plot across the 20 features included in the Random Forest model shown in descendent order. Abbreviations: OOBE, average out-of-bag error.

RESULTS

Aggregate Sample

Data from 1275 youth aggregated across contributing samples met inclusion criteria for subsequent analyses. Demographic, clinical, and other characteristics are in Figure 1B, Methods in eAppendix, eFigures 2 and 3, eTables 2-4. Most individuals (79%, n=1004), met diagnostic criteria for ASD; 17% (n=214) had ADHD without ASD, and 4% (n=57) had other NDDs, without ASD. Amongst 938 (80%) youth with available intelligence estimates, 62% (n=624) were in the Average/Above Average range, 14% (n=141) in the Borderline range, and 24% (n=173) had mild to profound intellectual disability. Over half (64%, n=811) of the caregivers had at least a college degree, the remaining had either a high school degree (30%), or elementary education (6%). Fifty-six percent of the aggregate dataset was of European/British ancestry (eTable4).

AFAR Factors

EFA and primary CFA conducted on the Prior scores of split-half samples yielded a single Adaptive Living Skills factor, two RRB-related factors (High- and Lower-order),33,46 and four Co-occurring Problem Behavior factors (Anxiety, Oppositional Behavior, Sleep Problems, Activity/Attention (eTables5 and 6). As in the general population,27 COVID-19 Worries yielded a single factor, while Daily Behaviors and Life Changes yielded multiple factors. Results remained consistent in secondary CFA across the entire sample on Current ratings (eTable 6).

Impact on Overall Sample

Only sleep problems reached statistically significant increases between Prior and Current scores (p=0.03, FDR corrected; Results in eAppendix). On average, children lost one service and had one other service continued, either at or outside school. Most continued services occurred as modified via telehealth/email (eFigure 4, eTable 7).

Pandemic Impact Subgroups

The four-factor cluster solution of COVID-19 impact was the most optimal (Figure3, eTable7, eFigure4). Based on their profile of deviations from the aggregate’s average of symptoms and/or service changes, the subgroups were: broad symptom worsening only (20%); primarily modified services (23%), primarily lost services (6%), and average symptom/service changes (53%). The broad symptom worsening only subgroup was characterized by more severe scores across all symptom domains as indexed by z scores >.5 (>.5 SD from the average aggregate), and by marginal service changes (i.e., within .5 SD from the average). The three remaining subgroups, totaling n=1024 (80% of the aggregate) showed symptom changes within the aggregate’s average (z scores < .5) but differed in service access. One subgroup had most services modified, another had most services lost, and a third subgroup had the number of services lost and continued like those of the aggregate. This overall symptom/service impact pattern was confirmed by follow up one-way ANOVAs and Tukey pairwise group mean comparisons (FDR q<0.05). Results remained largely similar after covarying for contributing samples, and in secondary cluster analyses on data subsets distinct by survey attrition rates (eTable7, eFigures4 and 5, Results in eAppendix).

Predictors

The RF model predicted subgroup membership with 81% accuracy (precision/sensitivity=82%, recall/specificity=75%). The top-ranked predictor (OOBE: 12 %) was the number of services received at school before the pandemic (Figure 2B). Six predictors followed with OOBE going from 6 to 1%. They included the number of services previously received outside school, COVID-19 rates, stringency index in the child’s location, lifestyle stress, COVID-19 Worries, and age (Figure 3, eTable 8). Baseline severity score prior to the pandemic was ranked eighth (<1%). Each subgroup was characterized by unique combinations of the pandemic, pre-pandemic, and demographic predictors (Figure4, eTable8).

Figure 3.
  • Download figure
  • Open in new tab
Figure 3. COVID-19 Impact Subgroups.

a) The dendrogram shows the optimal 4-cluster solution which included: broad symptom worsening only (n=251, 20%; yellow), primarily modified services (n=293, 23%; blue), primarily lost services (n=78, 6%; green), and average symptom/service changes (n=653, 53%; red). b) Group means and standard error bars of the e z scored symptom factor changes (difference between Current and Prior scores; or Δ) and number of services lost or modified in and outside (Out.) of school are shown for each cluster (i.e., impact subgroup). The dotted gray horizontal line at a z score 0 represents the aggregate sample mean (N=1275) across the features examined. Abbreviations: Adaptive Liv., Adaptive Living skills; RRB-LO, Restricted and Repetitive Behaviors - Lower Order; RRB-HO, Restricted and Repetitive Behaviors - Higher Order; Activ-Inatt, Activity Inattention; Sleep Prob., Sleep Problems; Out., Outside; Mod., Modified.

Figure 4.
  • Download figure
  • Open in new tab
Figure 4. Top-ranked Random Forest predictors by Impact Subgroups.

The radial plot shows the subgroup means across the eight top-ranked predictors resulting from the Random Forest analyses, color-coded by subgroup (Yellow=broad symptom worsening only; Red=average symptom/service changes; Blue=primarily modified services; Green=primarily lost services). Data are shown as z scores.

DISCUSSION

Prior disaster research in the general population, including COVID-19 pandemic studies,27,47,48 has consistently highlighted heterogeneity of mental health outcomes. The present study extends this insight into a multinational large sample of ASD/NDD youth by concomitantly assessing variability of changes in symptoms and therapeutic service access early in the pandemic. Across contributing samples, data-driven analyses identified four ASD/NDD subgroups: broad symptom worsening only (20%), primarily modified services (23%), primarily lost services (6%), and average symptom/service changes (53%). Their profiles revealed that symptom and service changes have distinct patterns of variation. The subgroup with notable clinical worsening did neither have the greatest number of services lost, nor the greatest number of continued services. Conversely, youth with relatively stable symptoms were parsed in three subgroups differing in service access. Recognizing these subgroups led to identify unique combinations of protective and risk factors, highlighting different pathways to either stable or worsening clinical presentations in ASD/NDD youth. The most robust predictors included factors common to the general population (e.g., COVID-19 worries), others ASD/NDD-specific (e.g., number of services received before), and age. Thus, the varying pandemic impact on symptoms in ASD/NDD youth is predicted by combinations of universal and ASD/NDD-related pre- and pandemic contexts in which service changes occur.

With one exception,20 the first wave of studies documenting the impact of the pandemic on ASD/NDD youth has consistently reported worsening behavioral and/or emotional problems,12,16,17,49,50 ASD symptoms,49,51 and/or sleep disruptions.10,12,50,52 Our results underscore that solely focusing on group-level effects leads to an incomplete picture of the COVID-19 pandemic impact on ASD/NDD. Multivariate analyses, across the whole sample, revealed that only sleep problems significantly worsened from pre- to pandemic times. While this group-level approach confirms earlier pandemic reports of increased sleep problems in ASD/NDD,12,15,50 it fails to recognize a more vulnerable subgroup. Cluster analysis revealed that 20% of the children worsened above and beyond their ASD/NDD peers. Worsening affected a broad range of symptoms, including sleep, externalizing, internalizing symptoms, RRB, and daily living skills. For the remaining participants, symptom changes pre- to pandemic were within the aggregate average - i.e., pandemic-related increases in sleep problems with other symptoms being relatively stable. Consistent with prior literature,8,9,51 our ASD/NDD sample experienced a variety of service disruptions, across settings, with either loss or telehealth modifications. However, variability was notable. Concomitantly clustering services and symptom changes further parsed the relatively clinically stable youth in three homogeneous subgroups differing by service access. This enabled a fine-grained identification of risk and resilience factors.

Employing AFAR in a multinational sample with varying COVID-19 rates and restrictions allowed the assessment of a broader range of predictors of impact than previously examined. The most relevant predictors of subgroup membership included risk factors common to the general population, and others more specific to ASD/NDD, such as pre-pandemic services, pandemic-related environment, and age. For example, elevated COVID-19 worries, and stress related to restrictions on leaving home and cancellations of important events distinguished the worsening subgroup. Consistent with prior disaster literature, 25,53 these factors have been identified as strong predictors of negative outcomes in recent general population pandemic studies.27,28 Our results underscore the impact of these stressors in clinical and non-clinical populations.

The present work also highlights the additional intricacies of understanding crisis impact on heterogeneous clinical populations. The number of services received prior to the pandemic was lower in the broad symptom worsening only subgroup versus two of the relatively stable ones: the primarily modified and the primarily lost services subgroups. In turn, these differed from each other for COVID-19 environmental context; the primarily modified services subgroup lived in areas with higher COVID-19 rates and greater restrictions than the primarily lost services one. Children experiencing the least pandemic-related changes relative to the aggregate sample, on average, were older (late childhood/preadolescence) than the other three subgroups. Especially in middle childhood, these findings indicate that more baseline services may foster resilience during a disaster. When living in areas with greater restrictions due to high COVID-19 rates, continuing services, even if modified, may lead to a relatively more stable clinical profile.

Pre-pandemic global clinical severity in ASD/NDD and other features related to clinical severity including diagnostic status, comorbidity rates, intellectual, and adaptive skills negligibly contributed to prediction. Most children across subgroups had equivalent baseline symptom severity, average intelligence, and mildly impaired adaptive functioning except for the mostly lost services subgroup which was characterized by greater impairment. These findings are in contrast with earlier ASD studies10,51 which suggest that pre-existing behavioral challenges related to greater problem behaviors following the pandemic. However, unlike the present effort, prior work focused on samples from relatively narrow geographical areas with largely homogeneous COVID-19 rates and institutional responses. The range of impacts and experiences of the COVID-19 pandemic, across our aggregate sample, allowed us to paint a more comprehensive picture of risk and resilience across ASD/NDD youth.

Our study has several limitations. First, considering time constraints on questionnaire completion, albeit comprehensive, AFAR could not assess all domains of impact and/or prediction. Symptoms least expected to change over a short period of time, were given lower priority, most notably, social-communication impairments.54 Given the protracted nature of the pandemic, future studies should include long-term assessment of social-communication skills. Similarly, although family demographics, parent education, and parent being an essential worker were included in our predictive model, parent’s mental health, recently reported to relate to children’s outcome during the pandemic,55–58 was not assessed. Second, although the aggregate sample includes youths with clinician-based diagnoses, previously collected measures of severity varied by contributing sample, and assessments of prior severity were based on parent responses in the AFAR survey. Nevertheless, we found that the AFAR baseline global severity scores correlated with standardized measures, when available. Third, our study did not include ASD/NDD preschoolers. Thus, although consistent with a prior report, 51 our results indicate that those in middle-childhood are at greater risk of impact; future studies specifically designed to target younger ages are needed. Finally, the present study focused on impact over the first six months of the pandemic using a cross-sectional design. Longitudinal coordinated study designs and infrastructures (e.g., common assessment measures) are needed to capture long-term outcomes and define stability of subgroups over time.

In sum, as in the general population, the COVID-19 pandemic impact varies across ASD/NDD youth. Risk and resilience are rooted in the pre- and pandemic contexts in which service disruptions occur. Provision of mental healthcare in preparation for, and during disasters are critical for ASD/NDD youth - further motivating efforts assessing effectiveness for telehealth and/or hybrid treatment programs. Finally, this study highlights the value of international data sharing and collaborations to address the needs of those most vulnerable.

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Additional Contributions

We are grateful to the research and clinical staff members at each contributing site supporting different aspects of collection of the AFAR surveys and the pre-pandemic clinical characterization. We thank Irene Droney at CMI for support in the development and curation of the AFAR website, RedCap data structure, Dr. Greg Kiar at CMI for helpful discussion about random forest classification, and Dr. Marco Pagani for helpful discussions on the use of NbClust in R. We are also thankful to Dr. Shafali Jeste for her sharing the preprint version of the service survey developed during the pandemic for individuals with syndromic intellectual disabilities and their caregivers that provided the model on which we developed the AAR service-related questions. Most importantly, we are immensely grateful to all parents/caregivers and their children who generously contributed their time during the pandemic, one of the most challenging times for humankind in this century.

Conflict of Interest Disclosures

Dr. Bishop receives royalties for the sale of diagnostic instruments she has co-authored (ADOS-2). Royalties generated from any of their own research or clinical activities are donated to charity.

Funding/Support

This work was partially supported by grants from the National Institute of Mental Health (R01MH105506, R01MH115363) and gifts to the Child Mind Institute (CMI) from Dr. John and Consuela Phelan for support of ADM; and from Phyllis Green and Randolph Cowen for MPM. We would also like to thank the many individuals who have provided financial support to the CMI Healthy Brain Network to make the creation and sharing of this resource possible; the Italian Ministry of Health, Ricerca Corrente 2021/2.06 to A.N., R.T. and G.M; The Ontario COVID & Kids Mental Health Study is funded by the Canadian Institutes for Health Research (#173092); the Ontario Ministry of Health (#700); Centre of Brain and Mental Health, SickKids; Leong Centre for Healthy Children, SickKids; and the Miner’s Lamp Innovation Fund in Prevention and Early Detection of Severe Mental Illness, University of Toronto. In-kind support was provided by the Ontario Brain Institute for all POND data. Spit for Science was funded by the Canadian Institutes of Health Research (PJT-159462). The views of the Ontario COVID & Kids Mental Health Study do not necessarily represent those of the Province of Ontario and the Ontario Ministry of Health.

Role of Funder/Sponsor

The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication

References

  1. 1.↵
    Unite N. Policy Brief: The Impact of COVID-19 on Children. UN; 2020.
  2. 2.↵
    Nearchou F, Flinn C, Niland R, Subramaniam SS, Hennessy E. Exploring the Impact of COVID-19 on Mental Health Outcomes in Children and Adolescents: A Systematic Review. Int J Environ Res Public Health. 2020;17(22). doi:10.3390/ijerph17228479
    OpenUrlCrossRef
  3. 3.↵
    Constantino JN, Sahin M, Piven J, Rodgers R, Tschida J. The Impact of COVID-19 on Individuals With Intellectual and Developmental Disabilities: Clinical and Scientific Priorities. Am J Psychiatry. 2020;177(11):1091–1093.
    OpenUrlPubMed
  4. 4.
    Fegert JM, Vitiello B, Plener PL, Clemens V. Challenges and burden of the Coronavirus 2019 (COVID-19) pandemic for child and adolescent mental health: a narrative review to highlight clinical and research needs in the acute phase and the long return to normality. Child Adolesc Psychiatry Ment Health. 2020;14(1):20.
    OpenUrlCrossRefPubMed
  5. 5.↵
    Courtenay K, Perera B. COVID-19 and people with intellectual disability: impacts of a pandemic. Ir J Psychol Med. 2020;37(3):231–236.
    OpenUrlCrossRefPubMed
  6. 6.↵
    Vohra R, Madhavan S, Sambamoorthi U, St Peter C. Access to services, quality of care, and family impact for children with autism, other developmental disabilities, and other mental health conditions. Autism. 2014;18(7):815–826.
    OpenUrlCrossRefPubMed
  7. 7.
    Carly Albaum M, Modica PT, Gorter JW, Nazilla Khanlou R, Lee V, Weiss J. Impact of COVID-19 on the Mental Health and Wellbeing of Caregivers and Families of Autistic people. Canad Institutes Health Res. Published online 2020. https://covid19mentalhealthresearch.ca/wp-content/uploads/2020/06/WEISS-Initial-Knowledge-Synthesis-Report_2020-06-22.pdf
  8. 8.↵
    Jeste S, Hyde C, Distefano C, et al. Changes in access to educational and healthcare services for individuals with intellectual and developmental disabilities during COVID-19 restrictions. J Intellect Disabil Res. Published online September 17, 2020. doi:10.1111/jir.12776
    OpenUrlCrossRef
  9. 9.↵
    White LC, Law JK, Daniels AM, et al. Brief Report: Impact of COVID-19 on Individuals with ASD and Their Caregivers: A Perspective from the SPARK Cohort. J Autism Dev Disord. Published online January 2, 2021. doi:10.1007/s10803-020-04816-6
    OpenUrlCrossRef
  10. 10.↵
    Colizzi M, Sironi E, Antonini F, Ciceri ML, Bovo C, Zoccante L. Psychosocial and Behavioral Impact of COVID-19 in Autism Spectrum Disorder: An Online Parent Survey. Brain Sci. 2020;10(6). doi:10.3390/brainsci10060341
    OpenUrlCrossRef
  11. 11.
    Panda PK, Gupta J, Chowdhury SR, et al. Psychological and Behavioral Impact of Lockdown and Quarantine Measures for COVID-19 Pandemic on Children, Adolescents and Caregivers: A Systematic Review and Meta-Analysis. Journal of Tropical Pediatrics. 2021;67(1). doi:10.1093/tropej/fmaa122
    OpenUrlCrossRef
  12. 12.↵
    Mutluer T, Doenyas C, Aslan Genc H. Behavioral Implications of the Covid-19 Process for Autism Spectrum Disorder, and Individuals’ Comprehension of and Reactions to the Pandemic Conditions. Front Psychiatry. 2020;11:561882.
    OpenUrlCrossRefPubMed
  13. 13.
    Jefsen OH, Rohde C, Nørremark B, Østergaard SD. Editorial Perspective: COVID-19 pandemic-related psychopathology in children and adolescents with mental illness. J Child Psychol Psychiatry. 2021;62(6):798–800.
    OpenUrl
  14. 14.
    Nonweiler J, Rattray F, Baulcomb J, Happé F, Absoud M. Prevalence and Associated Factors of Emotional and Behavioural Difficulties during COVID-19 Pandemic in Children with Neurodevelopmental Disorders. Children. 2020;7(9). doi:10.3390/children7090128
    OpenUrlCrossRef
  15. 15.↵
    Türkoglu S, Uçar HN, Çetin FH, Güler HA, Tezcan ME. The relationship between chronotype, sleep, and autism symptom severity in children with ASD in COVID-19 home confinement period. Chronobiol Int. 2020;37(8):1207–1213.
    OpenUrlPubMed
  16. 16.↵
    Asbury K, Fox L, Deniz E, Code A, Toseeb U. How is COVID-19 Affecting the Mental Health of Children with Special Educational Needs and Disabilities and Their Families? J Autism Dev Disord. 2021;51(5):1772–1780.
    OpenUrlPubMed
  17. 17.↵
    Amorim R, Catarino S, Miragaia P, Ferreras C, Viana V, Guardiano M. The impact of COVID-19 on children with autism spectrum disorder. Rev Neurol. 2020;71(8):285–291.
    OpenUrlPubMed
  18. 18.
    Zhang J, Shuai L, Yu H, et al. Acute stress, behavioural symptoms and mood states among school-age children with attention-deficit/hyperactive disorder during the COVID-19 outbreak. Asian J Psychiatr. 2020;51:102077.
    OpenUrl
  19. 19.↵
    Vasa RA, Singh V, Holingue C, Kalb LG, Jang Y, Keefer A. Psychiatric problems during the COVID-19 pandemic in children with autism spectrum disorder. Autism Res. 2021;(aur.2574). doi:10.1002/aur.2574
    OpenUrlCrossRef
  20. 20.↵
    Siracusano M, Segatori E, Riccioni A, Gialloreti LE, Curatolo P, Mazzone L. The Impact of COVID-19 on the Adaptive Functioning, Behavioral Problems, and Repetitive Behaviors of Italian Children with Autism Spectrum Disorder: An Observational Study. Children. 2021;8(2):96. doi:10.3390/children8020096
    OpenUrlCrossRef
  21. 21.↵
    Cost KT, Crosbie J, Anagnostou E, et al. Mostly worse, occasionally better: impact of COVID-19 pandemic on the mental health of Canadian children and adolescents. Eur Child Adolesc Psychiatry. Published online February 26, 2021. doi:10.1007/s00787-021-01744-3
    OpenUrlCrossRef
  22. 22.↵
    Lai MC, Kassee C, Besney R, et al. Prevalence of co-occurring mental health diagnoses in the autism population: a systematic review and meta-analysis. Lancet Psychiatry. 2019;6(10):819–829.
    OpenUrl
  23. 23.
    Kim SH, Macari S, Koller J, Chawarska K. Examining the phenotypic heterogeneity of early autism spectrum disorder: subtypes and short-term outcomes. J Child Psychol Psychiatry. 2016;57(1):93–102.
    OpenUrlCrossRef
  24. 24.↵
    Simonoff E, Pickles A, Charman T, Chandler S, Loucas T, Baird G. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry. 2008;47(8):921–929.
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    Bromet EJ, Havenaar JM. Psychological and perceived health effects of the Chernobyl disaster: a 20-year review. Health Phys. 2007;93(5):516–521.
    OpenUrlCrossRefPubMed
  26. 26.
    Bromet EJ, Atwoli L, Kawakami N, et al. Post-traumatic stress disorder associated with natural and human-made disasters in the World Mental Health Surveys. Psychol Med. 2017;47(2):227–241.
    OpenUrl
  27. 27.↵
    Nikolaidis A, Paksarian D, Alexander L, et al. The Coronavirus Health and Impact Survey (CRISIS) reveals reproducible correlates of pandemic-related mood states across the Atlantic. Sci Rep. 2021;11(1):8139.
    OpenUrl
  28. 28.↵
    Nikolaidis A, DeRosa J, Kass M, et al. Heterogeneity in COVID-19 pandemic-induced lifestyle stressors predicts future mental health in adults and children in the US and UK. J Psychiatr Res. 2022;147:291–300.
    OpenUrl
  29. 29.↵
    CRISIS AFAR, The CoRonavIruS Health Impact Survey (CRISIS). The CoRonavIruS Health Impact Survey (CRISIS). Accessed March 30, 2022. http://www.crisissurvey.org/crisis-afar/
  30. 30.↵
    Valenti M, Ciprietti T, Egidio CD, et al. Adaptive response of children and adolescents with autism to the 2009 earthquake in L’Aquila, Italy. J Autism Dev Disord. 2012;42(6):954–960.
    OpenUrlPubMed
  31. 31.↵
    Peters-Scheffer N, Didden R, Sigafoos J, Green VA, Korzilius H. Behavioral flexibility in children with autism spectrum disorder and intellectual disability. Research in Autism Spectrum Disorders. 2013;7(6):699–709. doi:10.1016/j.rasd.2013.02.016
    OpenUrlCrossRef
  32. 32.
    D’Cruz AM, Ragozzino ME, Mosconi MW, Shrestha S, Cook EH, Sweeney JA. Reduced behavioral flexibility in autism spectrum disorders. Neuropsychology. 2013;27(2):152–160.
    OpenUrlCrossRefPubMedWeb of Science
  33. 33.↵
    Bishop SL, Hus V, Duncan A, et al. Subcategories of restricted and repetitive behaviors in children with autism spectrum disorders. J Autism Dev Disord. 2013;43(6):1287–1297.
    OpenUrlCrossRefPubMed
  34. 34.↵
    Association AP, Others. DSM-4-TR. Published online 2004.
  35. 35.↵
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association; 2013.
  36. 36.
    World Health Organization. The International Statistical Classification of Diseases and Health Related Problems ICD-10: Tenth Revision. Volume 2: Instruction Manual. World Health Organization; 2004.
  37. 37.↵
    Maechler M, Rousseeuw P, Struyf A, Hubert M, Hornik K. Cluster: Cluster Analysis Basics and Extensions.(2021). R package version 2.1. 2–For new features, see the ‘Changelog’file (in the package source).
  38. 38.↵
    Murtagh F, Legendre P. Ward’s hierarchical agglomerative clustering method: Which algorithms implement ward’s criterion? J Classification. 2014;31(3):274–295.
    OpenUrl
  39. 39.↵
    Charrad M, Ghazzali N, Boiteau V, Niknafs A. NbClust: An R Package for Determining the Relevant Number of Clusters in a Data Set. Journal of Statistical Software, Articles. 2014;61(6):1–36.
    OpenUrl
  40. 40.↵
    Hale T, Petherick A, Phillips T, Webster S. Variation in government responses to COVID-19. Blavatnik school of government working paper. 2020;31:2020–2011.
    OpenUrl
  41. 41.
    Roser M, Ritchie H, Ortiz-Ospina E, Hasell J. Coronavirus pandemic (COVID-19). Our world in data. Published online 2020. https://ourworldindata.org/coronavirus/country/sweden?country=~SWE&fbclid=IwAR3JDc2cGwgfSuYly7pBg9hdMqlhwN--Z5UR1qjVWV_NB44KcPwwMexY9qM
  42. 42.↵
    Naqvi A. COVID-19 European regional tracker. doi:10.1101/2021.02.15.21251788
    OpenUrlAbstract/FREE Full Text
  43. 43.↵
    Genuer R, Poggi JM, Tuleau-Malot C. Variable selection using random forests. Pattern Recognit Lett. 2010;31(14):2225–2236.
    OpenUrlCrossRefWeb of Science
  44. 44.
    Alvarez-Fernandez S, Brown HR, Zhao Y, et al. Perceived social support in adults with autism spectrum disorder and attention-deficit/hyperactivity disorder. Autism Res. 2017;10(5):866–877.
    OpenUrl
  45. 45.↵
    Breiman L. Random Forests. Mach Learn. 2001;45(1):5–32.
    OpenUrlCrossRefPubMedWeb of Science
  46. 46.↵
    Georgiades S, Papageorgiou V, Anagnostou E. Brief report: Repetitive behaviours in Greek individuals with autism spectrum disorder. J Autism Dev Disord. 2010;40(7):903–906.
    OpenUrlCrossRefPubMed
  47. 47.↵
    Ellwardt L, Präg P. Heterogeneous mental health development during the COVID-19 pandemic in the United Kingdom. Sci Rep. 2021;11(1):15958.
    OpenUrlCrossRef
  48. 48.↵
    Ma Z, Idris S, Zhang Y, et al. The impact of COVID-19 pandemic outbreak on education and mental health of Chinese children aged 7–15 years: an online survey. BMC Pediatr. 2021;21(1):1–8.
    OpenUrlCrossRef
  49. 49.↵
    Martínez-González AE, Moreno-Amador B, Piqueras JA. Differences in emotional state and autistic symptoms before and during confinement due to the COVID-19 pandemic. Res Dev Disabil. 2021;116:104038.
    OpenUrl
  50. 50.↵
    Berard M, Rattaz C, Peries M, Loubersac J, Munir K, Baghdadli A. Impact of containment and mitigation measures on children and youth with ASD during the COVID-19 pandemic: Report from the ELENA cohort. J Psychiatr Res. 2021;137:73–80.
    OpenUrl
  51. 51.↵
    Bhat A. Analysis of the SPARK study COVID-19 parent survey: Early impact of the pandemic on access to services, child/parent mental health, and benefits of online services. Autism Res. 2021;14(11):2454–2470.
    OpenUrl
  52. 52.↵
    Bruni O, Melegari MG, Breda M, et al. Impact of COVID-19 lockdown on sleep in children with autism spectrum disorders. J Clin Sleep Med. 2022;18(1):137–143.
    OpenUrl
  53. 53.↵
    Miura I, Nagai M, Maeda M, et al. Perception of Radiation Risk as a Predictor of Mid-Term Mental Health after a Nuclear Disaster: The Fukushima Health Management Survey. Int J Environ Res Public Health. 2017;14(9). doi:10.3390/ijerph14091067
    OpenUrlCrossRef
  54. 54.↵
    Anagnostou E, Jones N, Huerta M, et al. Measuring social communication behaviors as a treatment endpoint in individuals with autism spectrum disorder. Autism. 2015;19(5):622–636.
    OpenUrlCrossRefPubMed
  55. 55.↵
    Fosco GM, Sloan CJ, Fang S, Feinberg ME. Family vulnerability and disruption during the COVID-19 pandemic: prospective pathways to child maladjustment. J Child Psychol Psychiatry. 2022;63(1):47–57.
    OpenUrl
  56. 56.
    Russell BS, Hutchison M, Tambling R, Tomkunas AJ, Horton AL. Initial Challenges of Caregiving During COVID-19: Caregiver Burden, Mental Health, and the Parent–Child Relationship. Child Psychiatry Hum Dev. 2020;51(5):671–682.
    OpenUrlCrossRef
  57. 57.
    Ueda R, Okada T, Kita Y, et al. Quality of life of children with neurodevelopmental disorders and their parents during the COVID-19 pandemic: a 1-year follow-up study. Sci Rep. 2022;12(1):4298.
    OpenUrl
  58. 58.↵
    Kalb LG, Badillo-Goicoechea E, Holingue C, et al. Psychological distress among caregivers raising a child with autism spectrum disorder during the COVID-19 pandemic. Autism Res. 2021;14(10):2183–2188.
    OpenUrl
Back to top
PreviousNext
Posted April 28, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
CRISIS AFAR: An International Collaborative Study of the Impact of the COVID-19 Pandemic on Youth with Autism and Neurodevelopmental Conditions
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
CRISIS AFAR: An International Collaborative Study of the Impact of the COVID-19 Pandemic on Youth with Autism and Neurodevelopmental Conditions
Bethany Vibert, Patricia Segura, Louise Gallagher, Stelios Georgiades, Panagiota Pervanidou, Audrey Thurm, Lindsay Alexander, Evdokia Anagnostou, Yuta Aoki, Catherine S.N. Birken, Somer L. Bishop, Jessica Boi, Carmela Bravaccio, Helena Brentani, Paola Canevini, Alessandra Carta, Alice Charach, Antonella Costantino, Katherine T. Cost, Elaine Andrade Cravo, Jennifer Crosbie, Chiara Davico, Alessandra Gabellone, Federica Donno, Junya Fujino, Cristiane Tezzari Geyer, Tomoya Hirota, Stephen Kanne, Makiko Kawashima, Elizabeth Kelley, Hosanna Kim, Young Shin Kim, So Hyun (Sophy) Kim, Daphne J. Korczak, Meng-Chuan Lai, Lucia Margari, Gabriele Masi, Lucia Marzulli, Luigi Mazzone, Jane McGrath, Suneeta Monga, Paola Morosini, Shinichiro Nakajima, Antonio Narzisi, Rob Nicolson, Aki Nikolaidis, Yoshihiro Noda, Kerri Nowell, Miriam Polizzi, Joana Portolese, Maria Pia Riccio, Manabu Saito, Anish K. Simhal, Martina Siracusano, Stefano Sotgiu, Jacob Stroud, Fernando Sumiya, Ida Schwartz, Yoshiyuki Tachibana, Nicole Takahashi, Riina Takahashi, Hiroki Tamon, Raffaella Tancredi, Benedetto Vitiello, Alessandro Zuddas, Bennett Leventhal, Kathleen Merikangas, Michael P Milham, Adriana Di Martino
medRxiv 2022.04.27.22274269; doi: https://doi.org/10.1101/2022.04.27.22274269
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
CRISIS AFAR: An International Collaborative Study of the Impact of the COVID-19 Pandemic on Youth with Autism and Neurodevelopmental Conditions
Bethany Vibert, Patricia Segura, Louise Gallagher, Stelios Georgiades, Panagiota Pervanidou, Audrey Thurm, Lindsay Alexander, Evdokia Anagnostou, Yuta Aoki, Catherine S.N. Birken, Somer L. Bishop, Jessica Boi, Carmela Bravaccio, Helena Brentani, Paola Canevini, Alessandra Carta, Alice Charach, Antonella Costantino, Katherine T. Cost, Elaine Andrade Cravo, Jennifer Crosbie, Chiara Davico, Alessandra Gabellone, Federica Donno, Junya Fujino, Cristiane Tezzari Geyer, Tomoya Hirota, Stephen Kanne, Makiko Kawashima, Elizabeth Kelley, Hosanna Kim, Young Shin Kim, So Hyun (Sophy) Kim, Daphne J. Korczak, Meng-Chuan Lai, Lucia Margari, Gabriele Masi, Lucia Marzulli, Luigi Mazzone, Jane McGrath, Suneeta Monga, Paola Morosini, Shinichiro Nakajima, Antonio Narzisi, Rob Nicolson, Aki Nikolaidis, Yoshihiro Noda, Kerri Nowell, Miriam Polizzi, Joana Portolese, Maria Pia Riccio, Manabu Saito, Anish K. Simhal, Martina Siracusano, Stefano Sotgiu, Jacob Stroud, Fernando Sumiya, Ida Schwartz, Yoshiyuki Tachibana, Nicole Takahashi, Riina Takahashi, Hiroki Tamon, Raffaella Tancredi, Benedetto Vitiello, Alessandro Zuddas, Bennett Leventhal, Kathleen Merikangas, Michael P Milham, Adriana Di Martino
medRxiv 2022.04.27.22274269; doi: https://doi.org/10.1101/2022.04.27.22274269

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Psychiatry and Clinical Psychology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)